Logo image of BKD

BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis

NYSE:BKD - US1124631045 - Common Stock

7.84 USD
+0.11 (+1.42%)
Last: 8/27/2025, 6:30:00 PM
7.68 USD
-0.16 (-2.04%)
After Hours: 8/27/2025, 6:30:00 PM
Fundamental Rating

2

Overall BKD gets a fundamental rating of 2 out of 10. We evaluated BKD against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BKD had negative earnings in the past year.
In the past year BKD had a positive cash flow from operations.
In the past 5 years BKD reported 4 times negative net income.
BKD had a positive operating cash flow in 4 of the past 5 years.
BKD Yearly Net Income VS EBIT VS OCF VS FCFBKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BKD has a worse Return On Assets (-3.95%) than 62.38% of its industry peers.
With a Return On Equity value of -230.26%, BKD is not doing good in the industry: 77.23% of the companies in the same industry are doing better.
BKD has a Return On Invested Capital of 0.88%. This is comparable to the rest of the industry: BKD outperforms 40.59% of its industry peers.
Industry RankSector Rank
ROA -3.95%
ROE -230.26%
ROIC 0.88%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKD Yearly ROA, ROE, ROICBKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BKD has a Operating Margin (1.94%) which is comparable to the rest of the industry.
BKD's Operating Margin has improved in the last couple of years.
The Gross Margin of BKD (25.98%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BKD has grown nicely.
Industry RankSector Rank
OM 1.94%
PM (TTM) N/A
GM 25.98%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKD Yearly Profit, Operating, Gross MarginsBKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKD is destroying value.
BKD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BKD has more shares outstanding
Compared to 1 year ago, BKD has an improved debt to assets ratio.
BKD Yearly Shares OutstandingBKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKD Yearly Total Debt VS Total AssetsBKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BKD has an Altman-Z score of -0.23. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.23, BKD is doing worse than 79.21% of the companies in the same industry.
BKD has a Debt/Equity ratio of 40.40. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 40.40, BKD is not doing good in the industry: 83.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 40.4
Debt/FCF N/A
Altman-Z -0.23
ROIC/WACC0.11
WACC8.14%
BKD Yearly LT Debt VS Equity VS FCFBKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.83 indicates that BKD may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.83, BKD is doing worse than 80.20% of the companies in the same industry.
BKD has a Quick Ratio of 0.83. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
BKD has a Quick ratio of 0.83. This is in the lower half of the industry: BKD underperforms 75.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
BKD Yearly Current Assets VS Current LiabilitesBKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BKD have decreased strongly by -14.13% in the last year.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.90%.
BKD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.08% yearly.
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%

3.2 Future

BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
Based on estimates for the next years, BKD will show a small growth in Revenue. The Revenue will grow by 1.26% on average per year.
EPS Next Y9.41%
EPS Next 2Y20.16%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.31%
Revenue Next 2Y-0.59%
Revenue Next 3Y1.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BKD Yearly Revenue VS EstimatesBKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKD Yearly EPS VS EstimatesBKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Also next year BKD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKD Price Earnings VS Forward Price EarningsBKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

BKD's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.36
BKD Per share dataBKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

BKD's earnings are expected to grow with 17.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.16%
EPS Next 3Y17.3%

More info and screens

0

5. Dividend

5.1 Amount

BKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKDALE SENIOR LIVING INC

NYSE:BKD (8/27/2025, 6:30:00 PM)

After market: 7.68 -0.16 (-2.04%)

7.84

+0.11 (+1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners99.83%
Inst Owner Change2.19%
Ins Owners0.8%
Ins Owner Change-14.05%
Market Cap1.86B
Analysts72
Price Target7.91 (0.89%)
Short Float %4.34%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.95%
Min EPS beat(2)-145.33%
Max EPS beat(2)-30.56%
EPS beat(4)0
Avg EPS beat(4)-69%
Min EPS beat(4)-145.33%
Max EPS beat(4)-25.67%
EPS beat(8)1
Avg EPS beat(8)-43.41%
EPS beat(12)4
Avg EPS beat(12)-13.85%
EPS beat(16)6
Avg EPS beat(16)6.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-1.07%
Revenue beat(12)0
Avg Revenue beat(12)-0.91%
Revenue beat(16)0
Avg Revenue beat(16)-0.97%
PT rev (1m)6.9%
PT rev (3m)10.71%
EPS NQ rev (1m)-1.59%
EPS NQ rev (3m)-21.38%
EPS NY rev (1m)-8.85%
EPS NY rev (3m)-28.75%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF 8.52
P/B 17.67
P/tB 23.85
EV/EBITDA 13.36
EPS(TTM)-1.05
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)0.92
OCFY11.74%
SpS13.44
BVpS0.44
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.95%
ROE -230.26%
ROCE 1.11%
ROIC 0.88%
ROICexc 0.92%
ROICexgc 0.92%
OM 1.94%
PM (TTM) N/A
GM 25.98%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 40.4
Debt/FCF N/A
Debt/EBITDA 9.64
Cap/Depr 163.45%
Cap/Sales 19.46%
Interest Coverage 0.25
Cash Conversion 49.49%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z -0.23
F-Score5
WACC8.14%
ROIC/WACC0.11
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y9.41%
EPS Next 2Y20.16%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%
Revenue Next Year2.31%
Revenue Next 2Y-0.59%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
EBIT growth 1Y24.43%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year528.67%
EBIT Next 3Y95.37%
EBIT Next 5YN/A
FCF growth 1Y-274.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.46%
OCF growth 3YN/A
OCF growth 5Y-5.14%